Group One Trading
OTLK icon

Group One Trading’s Outlook Therapeutics OTLK Stock Holding History

Group One Trading’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4K Buy
113,701
+76,704
+207% +$33.1K ﹤0.01% 5848
2025
Q4 		$58.5K Buy
36,997
+20,164
+120% +$32.2K ﹤0.01% 5476
2025
Q3 		$17.8K Sell
16,833
-10,471
-38% -$18.1K ﹤0.01% 6789
2025
Q2 		$43.7K Buy
27,304
+21,075
+338% +$33.6K ﹤0.01% 5690
2025
Q1 		$7.6K Buy
+6,229
New +$10.9K ﹤0.01% 6426

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Group One Trading's OTLK Position: Q1 2026 in Review

Group One Trading increased its Outlook Therapeutics (OTLK) stake by 207% in Q1 2026, buying an estimated $33.1K and bringing the position to 113,701 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5848.

Group One Trading first reported a position in OTLK in Q1 2025 and has held it in 5 quarters since. The position peaked at $58.5K in Q4 2025. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Group One Trading held 113,701 shares of Outlook Therapeutics worth $23.4K as of Q1 2026.
  • Group One Trading bought 76,704 Outlook Therapeutics shares in Q1 2026, an estimated $33.1K.
  • Outlook Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5848 holding.
  • Group One Trading first reported a position in Outlook Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Group One Trading's Outlook Therapeutics position peaked at $58.5K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.